The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...

Inflammation is linked to the development of psychiatric illness. Recently, data has emerged on the usefulness of treating ...

Supernus Pharmaceuticals has linked its mTORC1 activator to rapid improvements in adults with major depressive disorder in a ...

SNRIs are often preferred for treating more severe cases of depression. Common examples include duloxetine, desvenlafaxine ...

Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path ...

Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...

There was nothing else to do, so I was like, 'oh, I'll just go and do it, why not?'' It was once considered a 'dirty' drug ...

Scientists are learning more about how psychedelic mushrooms may alter the brain, potentially leading to long-lasting ...

Non-steroidal anti-inflammatory drugs have been used in small research trials in patients with arthritis and depression. They reported a significant improvement in depressive symptoms that was ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the ...

The drugmaker plans to prioritize the launch of its postpartum depression pill Zurzuvae, that has been jointly developed with ...